Galanin 2 Receptor: A Novel Target for a Subset of Pancreatic Ductal Adenocarcinoma.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Jun 2023
Historique:
received: 11 05 2023
revised: 06 06 2023
accepted: 13 06 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

Galanin is a 30 amino acid peptide that stimulates three subtype receptors (GAL

Identifiants

pubmed: 37373336
pii: ijms241210193
doi: 10.3390/ijms241210193
pmc: PMC10299363
pii:
doi:

Substances chimiques

Receptor, Galanin, Type 2 0
Galanin 88813-36-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Cancers (Basel). 2021 Nov 03;13(21):
pubmed: 34771675
Neurotherapeutics. 2021 Oct;18(4):2737-2752
pubmed: 34859381
Cell Tissue Res. 1991 May;264(2):263-7
pubmed: 1715240
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
J Med Chem. 2002 Aug 15;45(17):3746-54
pubmed: 12166947
Peptides. 2021 Feb;136:170468
pubmed: 33253776
STAR Protoc. 2022 Oct 26;3(4):101712
pubmed: 36317178
Histol Histopathol. 2005 Jul;20(3):745-52
pubmed: 15944923
PLoS One. 2017 Aug 30;12(8):e0182855
pubmed: 28854237
Front Oncol. 2021 Jul 15;11:688377
pubmed: 34336673
Pharmacol Rev. 2015;67(1):118-75
pubmed: 25428932
Lancet. 2016 Jul 2;388(10039):73-85
pubmed: 26830752
Drug Des Devel Ther. 2015 Jul 07;9:3529-45
pubmed: 26185420
Peptides. 2015 May;67:45-54
pubmed: 25797109
Cancer Discov. 2017 Aug;7(8):818-831
pubmed: 28572459
J Int Med Res. 2003 Mar-Apr;31(2):126-32
pubmed: 12760316
Cancers (Basel). 2022 Aug 01;14(15):
pubmed: 35954419
Cell Oncol (Dordr). 2022 Apr;45(2):241-256
pubmed: 35267186
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Exp Ther Med. 2016 Nov;12(5):3375-3380
pubmed: 27882166
Sci Rep. 2017 Apr 19;7:46600
pubmed: 28422162
Int J Cancer. 1998 Jan 30;75(3):396-9
pubmed: 9455800
Cancer. 2014 Jan 15;120(2):205-13
pubmed: 24122450
Peptides. 2010 May;31(5):893-8
pubmed: 20206220
Lancet. 2020 Jun 27;395(10242):2008-2020
pubmed: 32593337
Cell Tissue Res. 1991 May;264(2):363-8
pubmed: 1715243
J Pharmacol Toxicol Methods. 2010 Mar-Apr;61(2):210-8
pubmed: 20176117
Br J Cancer. 2010 May 25;102(11):1555-77
pubmed: 20502460
Exp Suppl. 2010;102:223-41
pubmed: 21299072
Mol Med Rep. 2014 Sep;10(3):1289-94
pubmed: 25017118
Oncol Lett. 2019 Jan;17(1):3-10
pubmed: 30655732
Chem Commun (Camb). 2022 May 24;58(42):6239-6242
pubmed: 35510683
Cell Physiol Biochem. 2021 Jan 29;55(1):61-90
pubmed: 33508184
Am J Physiol. 1972 Nov;223(5):1250-6
pubmed: 4347447
World J Gastroenterol. 2016 Nov 28;22(44):9694-9705
pubmed: 27956793

Auteurs

Pawel Namsolleck (P)

Lanthio Pharma, 9727 DL Groningen, The Netherlands.
PCDA Pharma Consulting & Data Analytics, 9791 CH Ten Boer, The Netherlands.

Barbara Kofler (B)

Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, Muellner Hauptstr. 48, 5020 Salzburg, Austria.

Gert N Moll (GN)

Lanthio Pharma, 9727 DL Groningen, The Netherlands.
Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Linnaeusborg, Nijenborg 7, 9747 AG Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH